Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OraVac phase 2b cholera vaccine trial in Zambian hotspots
PACTR202601530578513Phase 2Not yet recruiting
- Sponsor
- Zambia National Public Health Institute
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cholera, sponsored by Zambia National Public Health Institute. Primary endpoints: Positive conversion rate of anti-cholera toxin antibodies, Safety and 2 more. Planned start Feb 2026; status: not yet recruiting.
02
Conditions
cholera
Beyond the preview
Go deeper on PACTR202601530578513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202601530578513.